Our data suggest a pathophysiologic mechanism involving increased TRPC6 activity in response to the altered lipid content and substantiate the significance of research directed to the lipid metabolism in glomerular disease to open novel therapeutic avenues. The gene discussed is TRPC6; the disease is glomerular disorder.